Praxis Precision Medicines Financial Overview
Praxis Precision Medicines's market cap is currently $6.54B. The company's EPS TTM is $-3.36; its P/E ratio is ―; Praxis Precision Medicines is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-3.09. See an overview of income statement, balance sheet, and cash flow financials.
